Related Experiment Video
Updated: Jul 1, 2026

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model
Published on: September 14, 2009
Stents in total occlusion for restenosis prevention. The multicentre randomized STOP study. The Israeli Working Group
C Lotan1, Y Rozenman, A Hendler
1Hadassah University Hospital, Jerusalem, Israel.
Insights
Coronary stenting significantly reduces restenosis and reocclusion after balloon angioplasty for chronic total occlusions. While effective, diffuse in-stent restenosis necessitates careful stent selection and placement.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Chronic total occlusions (CTO) of coronary arteries present a significant challenge.
- Percutaneous transluminal coronary angioplasty (PTCA) for CTO has a high restenosis rate.
- Coronary stenting is explored as a method to reduce restenosis and reocclusion post-PTCA.
Purpose of the Study:
- To evaluate if coronary stenting improves outcomes after successful balloon angioplasty for CTO.
- To compare restenosis and reocclusion rates between PTCA alone and PTCA with stenting in CTO.
Main Methods:
- A multicentre randomized study involving 96 patients with CTO.
- Patients with optimal PTCA results were randomized to either no further treatment or stent implantation (AVE microstent).
- Clinical follow-up at 1, 3, and 6 months, with coronary angiography at 6 months or earlier if indicated.
Main Results:
- Stent implantation was successful in all patients with no major complications.
- Binary restenosis rates were significantly lower in the stent group (42.1%) compared to the PTCA group (70.9%) (P=0.034).
- Reocclusion rates were 7.9% in the stent group versus 16.1% in the PTCA group. Restenosis patterns differed: focal in PTCA, diffuse in-stent in the stented group.
Conclusions:
- Coronary stenting significantly decreases restenosis and reocclusion rates in CTO.
- The diffuse nature of in-stent restenosis suggests careful consideration of stent length and placement at the occlusion site.
Aims:
This multicentre randomized study set out to evaluate whether coronary stenting improves the results of successful balloon angioplasty for chronic total occlusion. Balloon angioplasty for chronic total occlusion has a high restenosis rate. Several reports have suggested that coronary stenting may decrease the likelihood of restenosis and reocclusion.
Methods And Results:
Patients with total coronary artery occlusions who had an optimal PTCA result were randomized either to no further treatment or additional stent implantation. The AVE microstent was used and all patients were scheduled for a 1-, 3-, and 6-month clinical follow-up. Repeat coronary angiography to assess the rate and pattern of restenosis was performed at 6 months or earlier if clinically indicated. Ninety-six patients were enrolled in this study. The mean age was 59. 3+/-10.3 years and 15 were females. Forty-eight patients were randomized to the stent arm, receiving 52 stents (lengths 18-39 mm). Stent implantation was successful in all and there were no major procedure-related complications. Sixty-nine patients (72%) were restudied after 6 months. The binary restenosis rates (50%), in the PTCA arm were 70.9% with a minimal lumen diameter of 1.01+/-0.79 mm compared to 42.1% in the stent arm with a minimal lumen diameter of 1.63+/-1.02 mm (P=0.034). Reocclusion occurred in 7.9% in the stent group compared to 16.1% in the PTCA group. Restenosis in the PTCA group was focal in 88% of patients and occurred at the point of total obstruction (within 5 mm), compared to diffuse instent restenosis, which occurred in 54% of the patients in the stent group.
Conclusion:
Coronary stenting can significantly decrease the rate of restenosis and reocclusion of total occlusions. As restenosis in the stent group was more diffuse, care should be taken to implant short stents at the site of occlusion.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care

